Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.7M Buy
59,987
+4,048
+7% +$839K 0.28% 50
2026
Q1
$12.6M Sell
55,939
-81
-0.1% -$20.2K 0.27% 44
2025
Q4
$13.5M Sell
56,020
-801
-1% -$205K 0.24% 50
2025
Q3
$15.6M Sell
56,821
-103
-0.2% -$28.1K 0.24% 46
2025
Q2
$14.7M Sell
56,924
-632
-1% -$151K 0.2% 47
2025
Q1
$12.9M Hold
57,556
0.16% 55
2024
Q4
$13.2M Sell
57,556
-178,160
-76% -$42.9M 0.16% 53
2024
Q3
$57.5M Sell
235,716
-53,372
-18% -$11.9M 0.6% 30
2024
Q2
$55.3M Hold
289,088
0.6% 29
2024
Q1
$57.2M Buy
289,088
+190,779
+194% +$35M 0.65% 27
2023
Q4
$16.9M Buy
98,309
+26,528
+37% +$4.08M 0.23% 43
2023
Q3
$10.6M Buy
71,781
+217
+0.3% +$39.2K 0.15% 57
2023
Q2
$15.6M Sell
71,564
-5,456
-7% -$1.22M 0.2% 46
2023
Q1
$16.9M Buy
77,020
+49,313
+178% +$10.7M 0.23% 44
2022
Q4
$5.77M Sell
27,707
-41
-0.1% -$9.01K 0.08% 55
2022
Q3
$6.06M Hold
27,748
0.08% 53
2022
Q2
$5.82M Buy
27,748
+2,864
+12% +$610K 0.07% 57
2022
Q1
$6.04M Buy
24,884
+2,640
+12% +$639K 0.07% 59
2021
Q4
$5.79M Hold
22,244
0.05% 63
2021
Q3
$5.86M Buy
22,244
+414
+2% +$113K 0.06% 61
2021
Q2
$5.38M Buy
21,830
+2,583
+13% +$543K 0.06% 62
2021
Q1
$3.73M Hold
19,247
0.04% 71
2020
Q4
$4.09M Hold
19,247
0.04% 68
2020
Q3
$3.3M Buy
+19,247
New +$3.55M 0.04% 67

Other funds holding RMD

C WorldWide Group's RMD Position: Q2 2026 in Review

C WorldWide Group increased its ResMed (RMD) stake by 7.2% in Q2 2026, buying an estimated $839K and bringing the position to 59,987 shares worth $11.7M. The position accounts for 0.28% of the portfolio, ranked #50.

C WorldWide Group first reported a position in RMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $57.5M in Q3 2024. 777 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • C WorldWide Group held 59,987 shares of ResMed worth $11.7M as of Q2 2026.
  • C WorldWide Group bought 4,048 ResMed shares in Q2 2026, an estimated $839K.
  • ResMed made up 0.28% of C WorldWide Group's portfolio in Q2 2026, its #50 holding.
  • C WorldWide Group first reported a position in ResMed in Q3 2020 and has held it in 24 quarters since.
  • C WorldWide Group's ResMed position peaked at $57.5M in Q3 2024.
  • 777 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.